CXCL10 and breast cancer: Intriguingly, the proportion of CXCL10+ cDCs in TNBC was much higher than that in estrogen receptor-positive (ER+) tumors (Fig. S2B), and the number of macrophages in TNBC was highest among the three breast cancer subtypes (Fig. S2C, D).